Back | Next |
home / stock / ions / ions message board
Subject | By | Source | When |
---|---|---|---|
Ionis receives $10 mln milestone payment from Biogen | Thoro | investorshub | 07/17/2017 5:09:35 PM |
$IONS Reuters info on Ionis: | Thoro | investorshub | 07/17/2017 5:07:47 PM |
Another successful Ph 3 clinical trial result... | shub | investorshub | 07/10/2017 6:43:08 PM |
https://seekingalpha.com/article/4086620-ionis-bullish-boost-phase-3-data | Inoviorulez | investorshub | 07/10/2017 2:39:29 PM |
7:47 am ET | shub | investorshub | 06/01/2017 7:30:37 PM |
Yeah, right...You shorts sure can get ugly. | shub | investorshub | 06/01/2017 7:28:56 PM |
https://seekingalpha.com/article/4073697-ionis-pharmaceuticals-falls-safety-risk | Inoviorulez | investorshub | 05/16/2017 8:57:04 PM |
Ions down today 9% despite the big PH | shub | investorshub | 05/15/2017 5:17:06 PM |
$IONS bullish 44.5086 | stocktrademan | investorshub | 05/11/2017 4:43:56 PM |
Chalk up a major point for $IONS! | shub | investorshub | 04/21/2017 6:46:35 PM |
$IONS and $OMER - For growth investors there | bratby | investorshub | 04/05/2017 9:14:43 PM |
It's about to get much worse with the | shub | investorshub | 03/13/2017 7:23:03 PM |
We are a smallish emerging bio, | shub | investorshub | 03/13/2017 7:20:40 PM |
I don't know the answer Percival; | shub | investorshub | 03/13/2017 7:19:00 PM |
Shorts must be leaking their fingers!! | jfkspire | investorshub | 03/13/2017 3:17:48 AM |
Must be painful with the losses to many Longs!! | jfkspire | investorshub | 03/13/2017 3:14:45 AM |
Is injection the only safe way to use | jfkspire | investorshub | 03/13/2017 3:11:45 AM |
Still beating us up over 5 injection site | shub | investorshub | 03/10/2017 8:11:15 PM |
The Pivotal Ph3 results on volanesorsen are in | shub | investorshub | 03/06/2017 7:37:42 PM |
Up 10% today after settling for quite a | shub | investorshub | 03/02/2017 6:37:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Ionis Pharmaceuticals Inc. Company Name:
IONS Stock Symbol:
NASDAQ Market:
Ionis Pharmaceuticals Inc. Website:
Ionis announces positive detailed results from the HALOS Study of ION582 in people with Angelman syndrome PR Newswire ION582 showed robust and consistent benefit in communication, cognition and motor function in a broad patient population evaluated with a comprehensive set o...
Ionis to hold second quarter 2024 financial results webcast PR Newswire Webcast scheduled for Thursday, August 1 at 11:30 a.m. Eastern Time CARLSBAD, Calif. , July 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced ...
Ionis completes enrollment in pivotal trial evaluating zilganersen in people living with Alexander disease PR Newswire Zilganersen is the first investigational medicine in clinical development for people with Alexander disease, a rare, life-threatening neurological condition...